Kendra A. Porath

Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma

Bianca M. Marin, Kendra A. Porath, Sonia Jain et al. · Neuro-Oncology · 2021 · 76 citations · Full text

Aberrant ATM signaling and homology-directed DNA repair as a vulnerability of p53-mutant GBM to AZD1390-mediated radiosensitization

Jiajia Chen, Daniel J. Laverty, Surabhi Talele et al. · Science Translational Medicine · 2024 · 28 citations · Full text

Bystander Effects, Pharmacokinetics, and Linker-Payload Stability of EGFR-Targeting Antibody-Drug Conjugates Losatuxizumab Vedotin and Depatux-M in Glioblastoma Models

Sonia Jain, Jessica I. Griffith, Kendra A. Porath et al. · Clinical Cancer Research · 2024 · 18 citations · Full text

IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade Glioma

Julian S. Rechberger, Kendra A. Porath, Liang Zhang et al. · Pharmaceutics · 2022 · 11 citations · Full text

Convection enhanced delivery of EGFR targeting antibody-drug conjugates Serclutamab talirine and Depatux-M in glioblastoma patient-derived xenografts

Kendra A. Porath, Michael S. Regan, Jessica I. Griffith et al. · Neuro-Oncology Advances · 2022 · 11 citations · Full text